OLUMIUS
Eli Lilly and Company
Application Filed: 2011-11-18
Trademark Application Details
Mark For: OLUMIUS™ trademark registration is intended to cover the categories of
This trademark application was refused, dismissed, or invalidated by the Office and this application is no longer active.
| Research |
OneLook
Acronym Finder
|
| Serial Number | 85476694 |
| Mark Literal Elements | OLUMIUS |
| Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
| Mark Type | Trademark |
| Current Location | INTENT TO USE SECTION 2014-01-31 |
| Basis | 1(b) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | No |
| Intent To Use | Yes |
| Filed ITU | Yes |
| 44D Filed | No |
| 44E Current | No |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Attorney Name | Bruce W. Longbottom |
| Law Office Assigned | L80 |
| Employee Name | GLASSER, CARYN |
Timeline
| 2011-11-18 | Application Filed |
| 2013-04-23 | Published |
| 2013-04-23 | Published for Opposition |
| 2014-01-31 | Location: INTENT TO USE SECTION |
| 2016-07-25 | Abandon |
| 2016-07-25 | Status: Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all docume |
| 2016-07-25 | Status: Dead/Abandoned |
| 2018-07-08 | Transaction Date |
Trademark Parties (Applicants & Owners)
| Party: |  Eli Lilly and Company |
| Address | Lilly Corporate Center Indianapolis, INDIANA UNITED STATES 46285 |
| Legal Entity Type | Corporation |
| Legal Entity State | INDIANA |
Documents
Application
DrawingAttorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorders, Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, pancreatic diseases and disorders, psychiatric disorders, sleep disorders, urological disorders; antipsychotic pharmaceutical preparations; antidepressants; Veterinary preparations, namely, vaccines, oral and injectable antimicrobial preparations for the treatment and control of infectious diseases in food producing animals and livestock, immunorestorative biopharmaceuticals, and other medicinal drugs for the prevention and treatment of viral, infectious, and metabolic diseases in animals; medicated animal feed and water additives in the nature of dietary supplements for production enhancement for livestock; veterinary preparations for controlling and destroying vermin, namely, ectoparasiticides, insecticides and parasiticides; Veterinary hormone preparations and hormone preparation implants for animals, namely, progesterone, estrogen and testosterone; Veterinary preparations for food safety, food animal processing and food animal processing aids, namely, bacteriophage, antimicrobials and vaccines to reduce levels of food borne pathogens carried in or on livestock, poultry or meat and to inhibit microbial decomposition in food and animal feed; veterinary preparations, namely, medical diagnostic agents, tests, and preparations and substances to identify pathogens and residues of biological interest for veterinary use; Veterinary preparations for companion animals, namely, to treat parasitic infections, diabetes, endocrine disorders, obesity, blood disorders, dental and oral diseases, pain, inflammation, gastrointestinal disorders, central nervous system disorders, neurological and neurodegenerative disorders, cardiovascular conditions, dermatologic conditions, urogenital and urinary conditions, osteoarthritis, otitis, wound healing, infections, allergy atopic conditions, liver diseases and disorders and nonsurgical sterilization, namely, hormones for the control/prevention of reproductive functions; veterinary preparations for treating and preventing fleas on companion animals; veterinary preparations, namely, vaccines for companion animals |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | 2016-07-25 | |
| ABANDONMENT - NO USE STATEMENT FILED | 2016-07-25 | 99999 |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2015-09-26 | |
| EXTENSION 5 GRANTED | 2015-09-25 | 70565 |
| TEAS EXTENSION RECEIVED | 2015-09-17 | |
| EXTENSION 5 FILED | 2015-09-17 | 70565 |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2015-06-04 | |
| EXTENSION 4 GRANTED | 2015-06-03 | 70565 |
| TEAS EXTENSION RECEIVED | 2015-05-22 | |
| EXTENSION 4 FILED | 2015-05-22 | 70565 |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2014-12-16 | |
| EXTENSION 3 GRANTED | 2014-12-15 | 70565 |
| TEAS EXTENSION RECEIVED | 2014-12-11 | |
| EXTENSION 3 FILED | 2014-12-11 | 70565 |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2014-06-17 | |
| EXTENSION 2 GRANTED | 2014-06-16 | 70565 |
| TEAS EXTENSION RECEIVED | 2014-06-10 | |
| EXTENSION 2 FILED | 2014-06-10 | 70565 |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2014-02-11 | |
| EXTENSION 1 GRANTED | 2014-02-10 | 70565 |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2014-01-31 | 70565 |
| TEAS EXTENSION RECEIVED | 2013-12-16 | |
| EXTENSION 1 FILED | 2013-12-16 | 70565 |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2013-06-18 | |
| PUBLISHED FOR OPPOSITION | 2013-04-23 | |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2013-04-23 | |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2013-04-03 | |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2013-03-18 | 73797 |
| ASSIGNED TO LIE | 2013-03-18 | 73797 |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2013-03-06 | |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2013-02-19 | 88889 |
| TEAS REQUEST FOR RECONSIDERATION RECEIVED | 2013-02-19 | |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2013-02-19 | 88889 |
| NOTIFICATION OF FINAL REFUSAL EMAILED | 2012-09-19 | |
| FINAL REFUSAL WRITTEN | 2012-09-19 | 82426 |
| FINAL REFUSAL E-MAILED | 2012-09-19 | |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2012-08-31 | 88889 |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2012-08-31 | |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2012-08-31 | 88889 |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2012-03-06 | 6325 |
| NON-FINAL ACTION WRITTEN | 2012-03-06 | 82426 |
| NON-FINAL ACTION E-MAILED | 2012-03-06 | 6325 |
| ASSIGNED TO EXAMINER | 2012-03-06 | 82426 |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2011-11-28 | |
| NEW APPLICATION ENTERED IN TRAM | 2011-11-22 |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 OLUMIUS 87074279 not registered Dead/Abandoned |
Eli Lilly and Company 2016-06-16 |
 OLUMIUS 85476694 not registered Dead/Abandoned |
Eli Lilly and Company 2011-11-18 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 